These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7879029

  • 1. Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
    Wang M, Stepkowski SM, Kahan BD.
    Transplant Proc; 1995 Feb; 27(1):383. PubMed ID: 7879029
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survival.
    Heidecke CD, Hancock WW, Jakobs F, Westerholt S, Sewzcik T, Deusch K, Zantl N, Kurrle R, Kupiec-Weglinski J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):540-2. PubMed ID: 8438405
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
    He G, Wang M, Xu H, Tian L, Yu J, Stepkowski SM, Kahan BD.
    Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
    [No Abstract] [Full Text] [Related]

  • 7. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ, Izycki DM, Zielinski M.
    Transplantation; 2003 Dec 27; 76(12):1662-8. PubMed ID: 14688512
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of graft-vs-host-related disease by host-specific natural killer cell activity following semiallogeneic small bowel transplantation in the rat.
    Fändrich F, Schröder J, Jahnke T, Dresske B, Chambers WH, Zavazava N.
    Transplant Proc; 1996 Dec 27; 28(6):3267-8. PubMed ID: 8962268
    [No Abstract] [Full Text] [Related]

  • 10. Irradiation of the donor combined with cyclosporine A treatment of the recipient prevents graft-versus-host disease and leads to prolonged survival of small-bowel allografts.
    Saat RE, de Bruin RW, Heineman E, Jeekel J, Marquet RL.
    Transplant Proc; 1990 Dec 27; 22(6):2465-6. PubMed ID: 2264111
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats.
    Fabian MA, Denning SM, Bollinger RR.
    Transplant Proc; 1992 Jun 27; 24(3):1174. PubMed ID: 1604575
    [No Abstract] [Full Text] [Related]

  • 13. Selective T-cell depletion of recipients in allogeneic small bowel transplantation (SBT) in the rat.
    Deaton DH, Posselt AM, Naji A, Barker CF.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 1):283-4. PubMed ID: 1899305
    [No Abstract] [Full Text] [Related]

  • 14. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML, Shaffer D, Ohzato H, Gottschalk R, Van der Werf WJ, Monaco AP.
    Transplant Proc; 1994 Jun 27; 26(3):1582. PubMed ID: 8030046
    [No Abstract] [Full Text] [Related]

  • 15. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF, Xiao F, Kociss K, Chong AS, Sankary HN, McChesney L, Cohn S, Williams JW.
    Transplant Proc; 1994 Jun 27; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract] [Full Text] [Related]

  • 16. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G, Zhong R, Zhang Z, Garcia B, Black R, Duff J, Grant D.
    Transplant Proc; 1992 Jun 27; 24(3):1178. PubMed ID: 1604577
    [No Abstract] [Full Text] [Related]

  • 17. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G, McAlister VC, Lee TD, Bitter-Suermann H, Theal M, Wright J, MacDonald AS.
    Transplant Proc; 1994 Jun 27; 26(3):1613. PubMed ID: 8030057
    [No Abstract] [Full Text] [Related]

  • 18. Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.
    Collins BH, Areford ML, Fabian MA, Jaffee BD, Bollinger RR.
    Transplant Proc; 1993 Jun 27; 25(3 Suppl 2):37-9. PubMed ID: 8516941
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H, Kaihara S, Egawa H, Inomata Y, Tanaka K, Yamaoka Y.
    Transplant Proc; 1996 Oct 27; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.